NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

NCT06963034 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: NBI-1117568
DRUG: Placebo

Sponsor

Neurocrine Biosciences